Health
Oxford-Astra COVID vaccine shows dual immune action: Researcher – BNN
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
The vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers. The results were published Monday in The Lancet medical journal.
We are seeing very good immune responses, not just on neutralizing antibo…
-
General20 hours agoVote counting begins for Townsville mayoral by-election
-
General22 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
Business10 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
General23 hours agoPolice to patrol Melbourne shopping centres in 90-day youth crime prevention trial